These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6112021)

  • 21. Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities.
    Neppe VM
    J Clin Psychiatry; 1983 Sep; 44(9):326-31. PubMed ID: 6355069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Administration of naloxone in schizophrenic psychoses and manic syndromes].
    Verhoeven WM; van Praag HM; de Jong JT
    Ned Tijdschr Geneeskd; 1981 Apr; 125(14):532-7. PubMed ID: 6112715
    [No Abstract]   [Full Text] [Related]  

  • 23. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
    Lee SW; Lee JG; Lee BJ; Kim YH
    Int Clin Psychopharmacol; 2007 Mar; 22(2):63-8. PubMed ID: 17293705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
    Akhondzadeh S; Gerami M; Noroozian M; Karamghadiri N; Ghoreishi A; Abbasi SH; Rezazadeh SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1810-5. PubMed ID: 18727948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study.
    Lotstra F; Verbanck P; Mendlewicz J; Vanderhaeghen JJ
    Biol Psychiatry; 1984 Jun; 19(6):877-82. PubMed ID: 6378259
    [No Abstract]   [Full Text] [Related]  

  • 26. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metiapine: a double-blind evaluation in chronic schizophrenic patients.
    Gallant DM; Bishop MP; Guerrero-Figueroa R
    Curr Ther Res Clin Exp; 1971 Dec; 13(12):734-6. PubMed ID: 5001741
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of schizophrenia with a vasopressin analogue.
    Iager AC; Kirch DG; Bigelow LB; Karson CN
    Am J Psychiatry; 1986 Mar; 143(3):375-7. PubMed ID: 3513631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydergine for schizophrenia.
    Cohen MR; Pary R; Burns R
    J Clin Psychiatry; 1987 Jan; 48(1):39-40. PubMed ID: 3542983
    [No Abstract]   [Full Text] [Related]  

  • 30. A pilot study of pimozide in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):706-13. PubMed ID: 5000718
    [No Abstract]   [Full Text] [Related]  

  • 31. Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study.
    Stryjer R; Strous R; Bar F; Shaked G; Shiloh R; Rozencwaig S; Grupper D; Buchman N; Kotler M; Rabey JM; Weizman A
    Hum Psychopharmacol; 2004 Jul; 19(5):343-6. PubMed ID: 15252826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amisulpride: a review of its efficacy in schizophrenia.
    Möller HJ
    Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activity and acceptability of indalpine in a double-blind study versus placebo].
    Gisselmann A
    Encephale; 1984; 10(5):231-4. PubMed ID: 6151492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
    Gálfi B; Benson K; Grynaeus T
    Int Pharmacopsychiatry; 1973; 8(1):37-59. PubMed ID: 4595192
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of the schizophrenic patient in a community psychiatric practice.
    Tobin JM
    Dis Nerv Syst; 1968 May; 29(5):Suppl:27-34. PubMed ID: 4876987
    [No Abstract]   [Full Text] [Related]  

  • 36. Penfluridol: once-a-week oral maintenance neuroleptic in the management of chronic schizophrenics.
    Kurland AA; Ota KY
    Psychopharmacol Bull; 1975 Jan; 11(1):12-4. PubMed ID: 1091943
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of clinical efficacy of pimozide as maintenance therapy in chronic schizophrenic patients.
    Singh AN
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):695-705. PubMed ID: 5000717
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of aqueous pineal extract in chronic schizophrenia.
    Bigelow LB
    Biol Psychiatry; 1974 Feb; 8(1):5-15. PubMed ID: 4592789
    [No Abstract]   [Full Text] [Related]  

  • 39. Two pilot studies of AHR-1680 in chronic schizophrenic patients.
    Sugerman AA; Herrmann J; O'Hara M; Simpson GM; Angus JW; Deutsch L
    J Clin Pharmacol J New Drugs; 1969; 9(3):183-6. PubMed ID: 4892454
    [No Abstract]   [Full Text] [Related]  

  • 40. Penfluridol (R 16341) as a maintenance therapy in chronic psychotic patients: a double-blind clinical evaluation.
    Roelofs GA
    Acta Psychiatr Scand; 1974; 50(2):219-24. PubMed ID: 4604881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.